SGLT2 inhibition reprograms systemic metabolism via FGF21-dependent and -independent mechanisms-Reference-Cited by-同舟云学术

SGLT2 inhibition reprograms systemic metabolism via FGF21-dependent and -independent mechanisms

Published:2019-03-07 Issue:5 Volume:4 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Osataphan Soravis,Macchi Chiara,Singhal Garima,Chimene-Weiss Jeremy,Sales Vicencia,Kozuka Chisayo,Dreyfuss Jonathan M.,Pan Hui,Tangcharoenpaisan Yanin,Morningstar Jordan,Gerszten Robert,Patti Mary-Elizabeth

Funder

Janssen Pharmaceuticals

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/123130/files/pdf

Reference51 articles.

1. Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial

2. Dose-Ranging Effects of Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, as Add-On to Metformin in Subjects With Type 2 Diabetes

3. Canagliflozin and cardiovascular and renal events in type 2 diabetes;Neal;N Engl J Med,2017

4. Effectiveness of Ipragliflozin, a Sodium-Glucose Co-transporter 2 Inhibitor, as a Second-line Treatment for Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus Who Do Not Respond to Incretin-Based Therapies Including Glucagon-like Peptide-1 Analogs and Dipeptidyl Peptidase-4 Inhibitors

5. Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients

Cited by 164 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fine mapping-based multi-omics analysis interprets the gut-lung axis function of SGLT2 inhibitors;Frontiers in Cellular and Infection Microbiology;2024-09-10

2. Sodium-Glucose Cotransporter 2 Therapy for Acute Organ Dysfunction in Critically Ill Patients;JAMA;2024-08-06

3. Dapagliflozin attenuates fat accumulation and insulin resistance in obese mice with polycystic ovary syndrome;European Journal of Pharmacology;2024-08

4. EValuating the Effect of periopeRaTIve empaGliflOzin on cardiac surgery associated acute kidney injury: rationale and design of the VERTIGO study;Clinical Kidney Journal;2024-07-22

5. The potential anti-arrhythmic effect of SGLT2 inhibitors;Cardiovascular Diabetology;2024-07-15